The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 27.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 3.00 (11.111%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
ALT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Postponement of results and trading update

30 Sep 2020 07:00

RNS Number : 5127A
Altitude Group PLC
30 September 2020
 

30 September 2020

 

Altitude Group plc

(the "Company" or "Altitude")

Postponement of Results and Trading Update

 

Altitude Group plc (AIM: ALT), the operator of the leading marketplace for personalised products, provides an update on its results for the 15 month-period ended 31 March 2020.

 

In line with the Financial Reporting Council ("FRC") guidance*, the Company now expects to release its results for the 15 month-period ended 31 March 2020 by the end of October 2020. This delay is caused by the impact of the coronavirus pandemic on the audit, including the remote audit process of the Company's main operations in the US and the impact of business disruption on judgmental balance sheet valuations. While the Board cannot be certain as to the level of adjustments that the auditors may take in relation to the coronavirus pandemic effects on the Company's operations until their work is fully concluded, management expects to report the following for the 15 months period ending 31 March 2020:

 

· Revenue from continuing operations not less than £8.0 million**

· Comparable revenue for the 12 months ending 31 December 2018 was £2.9 million

· Cash position of £2.4 million

The Company can also report that the cash position at 31 August 2020 was £1.6 million which was in line with management's expectations. The Company continues to be cautious in relation to managing cash and discretionary spending. Following the cessation of the US Payroll Protection Programme, the Company instituted a temporary 20% salary reduction for the management team and temporary reduction in staffing hours for all other employees in both the US and the UK.

 

Current Trading

 

The Company has continued to trade and support its distributor and supplier customers through the worst period of lockdown. As previously detailed 25% of US revenue is not reliant on transactional volume.

 

Recent industry reporting indicates that market transactional volume was 44% down in the June quarter vs 2019 but improved in July to 29% down and was steady in August at 26% down. Smaller and medium sized distributors are reported to be slightly higher in terms of year on year reductions. The slower rate of improvement in August has tempered industry expectations for a V shaped recovery and whilst August may be indicative of a longer and slower climb through 2020 and into 2021, it is currently impossible to predict with any degree of certainty.

 

We have retained 175 suppliers within the Preferred Supplier Programme and AIM Smarter distributor membership has held steady and currently stands at 2,103, who collectively historically delivered aggregate annual revenues of circa $2.2 billion to end-users.

 

We look forward to providing a further update with our full Preliminary Results on 30th October.

 

* Financial Reporting Council ("FRC") guidance states, "Companies, and in particular their audit committees, understand it is vital that auditors have sufficient time and support to carry out their work to an appropriate standard, including reassessing work done to reflect changed circumstances - in some cases, this may need companies to reconsider their reporting deadlines. Taken from FRC Guidance on audit issues arising from the Covid-19 (Coronavirus) pandemic, 16 March 2020.

 

** Continuing Operations exclude Ad Products which has been sold.

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. The above notification is made in accordance with the requirements of the EU Market Abuse Regulation.

 

Enquiries:

 

Altitude Group plc

Nichole Stella, Chief Executive Officer

Graeme Couturier, Chief Financial Officer

Keith Edelman, Non-Executive Chairman

Via Instinctif - 020 7457 2020

finnCap ltd

Jonny Franklin-Adams (Corporate Finance)

Charlie Beeson (Corporate Finance)

Richard Chambers (ECM)

 020 7220 0500 

Instinctif Partners (Financial PR)

Matthew Smallwood

Chantal Woolcock

020 7457 2020 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLLMBTMTTTTIM
Date   Source Headline
5th Jan 20246:06 pmRNSDirector/PDMR Dealing
12th Dec 20236:04 pmRNSDirector/PDMR Dealing
11th Dec 20237:00 amRNSHistoric Related Party Transactions
30th Nov 20237:00 amRNSHoldings in Company and Director Dealing
28th Nov 20237:00 amRNSInterim Results
24th Nov 20237:00 amRNSInvestor Presentation
27th Oct 20237:00 amRNSTrading Update and Director Share Awards
15th Sep 20237:00 amRNSResult of AGM
18th Aug 20237:00 amRNSPosting of Annual Report and Accounts
26th Jul 202312:00 pmRNSInvestor Presentation via Investor Meet Company
25th Jul 20237:00 amRNSAudited Final Results and Notice of AGM
20th Jul 20237:00 amRNSNotice of Results
8th Jun 20237:00 amRNSPre-Close Trading Update
11th Apr 20234:43 pmRNSDirector Dealing
29th Mar 20237:05 amRNSDirector Dealing
29th Mar 20237:00 amRNSHoldings in Company and Director Dealing
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20232:05 pmRNSSecond Price Monitoring Extn
28th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSMajor Contract Wins and Trading Update
16th Feb 20237:00 amRNSHolding(s) in Company
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSTrading Update
17th Jan 20237:00 amRNSAltitude Group PLC at Industry’s Largest Shows
9th Dec 20227:00 amRNSAltitude Group to Present at MelloMonday
29th Nov 20221:59 pmRNSInvestor Presentation
29th Nov 20227:00 amRNSInterim Results
22nd Nov 20227:00 amRNSTrading Update
31st Oct 20227:00 amRNSDirector/PDMR Dealing
28th Oct 20227:00 amRNSGrant of Options
25th Oct 20227:00 amRNSTrading Update
15th Sep 202212:54 pmRNSResult of AGM
6th Sep 20222:40 pmRNSOnline Access to AGM
5th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSAudited Final Results and Notice of AGM
17th Jun 20227:00 amRNSDirector Dealings, Exercise & Grant of Options
31st Mar 20227:00 amRNSTrading Update & Secured Credit Facility
11th Feb 20227:00 amRNSDirector/PDMR Dealing
10th Feb 20227:00 amRNSDirector/PDMR Dealing
1st Dec 20217:00 amRNSDirector/PDMR Dealings
30th Nov 20217:00 amRNSInterim Results
25th Nov 20217:00 amRNSHolding(s) in Company
24th Nov 20217:00 amRNSBoard Changes and Trading Update
5th Oct 20217:00 amRNSAppointment of CFO & Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.